Cannabis Countdown: Top 10 Marijuana and Psychedelic News of the Week

Welcome to Countdown to cannabis, the legal marijuana industry’s curated weekly news bulletin.

In this week’s edition, we summarize and count down the 10 most recent stories about cannabis and psychedelic stocks for the week of February 8-14, 2021.

Without further ado, let’s get started.

* Yahoo Finance readers, thank you click here to view the full article.

10. Pot Stocks Cap Off Week of Euphoric Gains, Top 30 Performers of the Week and YTD 2021

Investor euphoria in the cannabis sector reached a fever this week as pot containers became parabolic and produced gains of up to 238.89% in just 3 days

It’s official; that American Cannabis Boom 2.0 is in full swing as major market catalysts in the form of US federal Marijuana reforms seem imminent. With federal legalization in the United States closer to becoming a reality, money is flowing into the United States Cannabis market like never before, and as a result Pot storage has already seen astonishing YTD 2021 gains of up to 359.37%, 694.78% and 945.71%.

READ FULL TOPPOT STOCK ARTICLE HERE

9. Advocate for psychedelics, investor Zappy says 2021 is ‘the year to invest in herbal medicine’

Get into psychedelics now, it’s according to Michael “Zappy” Zapolin, a former Bear Stearns VP beaten psychedelic lawyer and filmmaker

Zappy’s call to invest comes as Psychedelics make a continued push towards credibility in the medical, legal and business phase. The market – expected to be valued at over $ 6.8 billion in North America by 2027 – is currently led by MindMed (OTCQB: MMEDF), Cybin Inc. (OTC: CLXPF), Field Trip Health (OTC: FTRPF). Last month, the first ETF for PsychedelicsHorizons Psychedelic Stock Index ETF (NEO: PSYK) – began trading in the Canadian NEO exchange. This is fertile ground for Zappy, who has a track record of getting into the ground floor.

READ FULL PSYCHEDELICS INVESTMENT ARTICLE

8. Portnoy turns solar growers into K-profit: ‘How to do it boys’

Thursday morning, Portnoy tweeted that he was “back in $ SNDL because I love Rush.” and approx. 25 minutes later, Portnoy hinted that he had turned the volatile stock for a big win

Solar growers (NASDAQ: SNDL) shares traded down 14% in massive volume in an extremely volatile trading session on Thursday after the company became one of the latest stocks targeted by communities of online traders, led by Save your WallStreetBets community. Bar stool sport founder Dave Portnoy took a big bath on his first round of WallStreetBets meme-stock buyer, but Portnoy said he earned a quick $ 50,000 by getting in and out of the sundial on Thursday.

READ FULL PORTNOY SUNDIAL ARTICLE

7. COMPASS Pathways expands its discovery center through new collaborations with world-leading researchers

Adam Halberstadt and John McCorvy join Jason Wallach to develop new psychedelic connections at the Virtual Discovery Center

Compass roads (NASDAQ: CMPS) announced that it has expanded its Discovery Center through collaboration with world-leading laboratories at UC San Diego, the School of Medicine and the Medical College of Wisconsin (MCW). Adam Halberstadt PhD, Associate Professor, Psychiatry, UC San Diego and John D McCorvy PhD, Assistant Professor, Department of Cell Biology, Neurobiology and Anatomy, MCW, and their teams, will join Jason Wallach PhD, Assistant Professor of Pharmaceutical Sciences, University of the Sciences (Philadelphia) at the Discovery Center, a group of researchers working virtually together.

READ ARTICLE FULL COMPASE STEEPER

6. Red White & Bloom arranges approx. $ 13.5 million to finance its final cost of acquiring Illinois

RWB received an $ 8 million Drawing assignment from an institutional investor and signed an irrevocable $ 7 million. Non-convertible bond entity financing obligation

Red White & Bloom (OTCQX: RWBYF) announced that they have arranged the required cash for the closure of the previously announced acquisition of an Illinois license for adult use and medical cannabis cultivation and related assets. After closure and subject to regulatory approval, the company intends to introduce both of its own Platinum Vape and High Times branded goods in Illinois market. “Illinois, which only exceeded $ 1 billion. USD of sales to adults, has only developed into one of the most robust revenue markets in the United States. With funding now secured, we are excited to be one step closer to bringing Red White & Bloom’s nationally recognized brands to this market. The renewed optimism surrounding the state, which allows an additional 75 stores, further highlights the enormous opportunity Illinois offers. ”

READ FULL RED WHITE & BLOOM ARTICLE

5. Creso Pharma Makes Movement To Accelerate Sales Growth And Increase Profit Margins

In response to a growing trend of direct inbound cannaQIX sales inquiries, Creso is officially taking over the reins from its Swiss commercial partner Doetsch Grether

Creso Pharma (OTC: COPHF) announced that the company has brought sales and marketing of its cannaQIX product internally. By doing this, Creso Pharma will be able to significantly improve its profit margin on the product. The move will also set the stage for Creso to expand existing product lines and launch new products such as cannaDOL in Switzerland.

READ THE FULL CRESO PHARMA ARTICLE

4. Incannex shares jump as Cannabis / Psychedelic Pharma Company explores double listing on NYSE or NASDAQ

The timing seems to be right, as both the cannabis and psychedelic sectors are definitely looking in Vogue at the moment, following efforts for legislative reform and increased acceptance across the globe

Incannex Healthcare (FROM: IQI) has announced that it will investigate a double listing in the US, a groundbreaking move that will give the drug development company access to the world’s largest pool of capital as it works to develop cannabis and psychedelic-based therapies. Incannex shares reached a near seven-year high after the Melbourne-based company said it had signed EAS Advisors as consultants to introduce it to US banks and institutions. The goal is to achieve a double listing on New York Stock Exchange (NYSE) or the NASDAQ, while preserving one ASX listing.

READ FULL INCANNEX ARTICLE

3. Aurora records 2nd quarter earnings, says 562% increase in cannabis sales of ‘International Medical’

Total cannabis net sales hovered $ 70.3 million, excluding provisions of $ 2.7 million, an increase of 11% in the second quarter of 2020

Aurora Cannabis (SNEEZE: ACB) released the second quarter financial year 2021 Earnings reports Thursday afternoon. Here is what we learned: Medical cannabis net sales reached $ 38.9 million – an increase of 42% over the second quarter of 2020. This jump was due to a 562% increase in international medical sales by a high margin. Aurora experienced an adjusted EBITDA loss of $ 12.1 million. That is an improvement of $ 53.1 million in the second quarter of 2020.

READ THE FULL AURORA CANNABIS ARTICLE

2. MindMed signs partnership with Swiss psychedelic drug discovery startup MindShift Compounds AG, expands development pipeline and IP portfolio with next-generation psychedelic and empatogenic connections

As part of this partnership, MindMed and MindShift Compounds AG have agreed to develop the next generation of psychedelic and empatogenic drugs together.

MindMed (OTCQB: MMEDF) (FROM: MMQ) announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent the next generation Psychedelic compounds with psychedelic or empatogenic properties. The first initial compounds have already been synthesized by MindShift Compounds AG, and related patent applications were filed by MindMed. MindMed plans to begin Phase 1 clinical trials in the first phase as early as Q1 2022 through its existing clinical trial platform for psychedelic and empatogenic compounds in Switzerland.

READ FULL REMEMBER ARTICLE

1. Why MSOs from cannabis ‘surpass the S&P 500’ in 2021

Top cannabis analyst Pablo Zuanic’s new estimates reflect Cantor Fitzgerald’s state assumptions

Most American Multi-State Operators (MSOs) according to the S & P500 in the coming year Cantor Fitzgerald analyst Pablo Zuanic. A couple of standouts in Zuanic’s Thursday note about the room include Ayr strategies (OTCQX: AYRSF), Green thumb ((OTCQX: GTBIF) and Jushi Holdings (OTCQB: JUSHF).

FULLY READ CANNABIS MSOS ARTICLE

‘Photo of Matthew Brodeur on Uplash

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Spread the love
[ Sharing is Caring! ]

More Tags We Love

auto insurance rates in florida increasing top 10 health insurance companies in canada business mobile phone insurance cover how much is insurance for new drivers auto insurance cost cheapest minimum auto insurance in west virginia doctors car insurance insurance companies in canada cheapest healthcare insurance in california who has cheapest auto insurance

This div height required for enabling the sticky sidebar